Table 1. - Frequency of isolated multiresistant bacteria in clinical samples from patients with and without cirrhosis.
Bacteria | With cirrhosis | Without cirrhosis | ||
Total n | MR n (%) | Total n | MR n (%) | |
Gram-positive † | ||||
S. aureus | 61 | 29 (16.7) | 469 | 211 (11.8) |
Enterococcus sp. | 43 | 1 (0.6) | 169 | 5 (0.4) |
S. viridans | 18 | 1 (0.6) | 50 | 1 (<0.1) |
Other Gram-positive bacteria | 31 | 0 | 165 | 0 |
E. faecium | 10 | 7 (4.0) | 56 | 46 (2.6) |
E. faecalis | 8 | 0 | 59 | 3 (0.2) |
Gram-negative | ||||
Enterobacteria | ||||
E. coli | 153 | 70 (40.2) | 992 | 553 (31.0) |
K. pneumoniae | 53 | 28 (16.1) | 434 | 201 (11.3) |
Enterobacter sp. | 22 | 9 (5.2) | 266 | 119 (6.7) |
Other enterobacteria | 9 | 0 | 99 | 22 (1.2) |
Proteus sp. | 8 | 3 (1.7) | 143 | 26 (1.4) |
Serratia sp. | 4 | 1 (0.6) | 128 | 18 (1.0) |
K. oxytoca | 0 | 0 | 52 | 21 (1.2) |
Nonfermenting Gram-negative Bacilli | ||||
P. aeruginosa | 12 | 7 (4.0) | 482 | 219 (12.3) |
Acinetobacter sp. | 12 | 10 (5.7) | 253 | 238 (13.3) |
Other Nonfermenting Gram-negative Bacilli | 11 | 1 (0.6) | 115 | 52 (2.9) |
S. maltophilia | 4 | 4 (2.3) | 44 | 44 (2.5) |
A. xylosoxidans | 3 | 3 (1.7) | 4 | 4 (0.2) |
Other Gram-negative Bacteria | 2 | 0 | 61 | 0 |
Total of evaluated bacteria | 464 | 174 (100) | 4,041 | 1,783 (100) |
Data are presented as the number of samples obtained by direct counting (percentage). MR: multiresistant. † Coagulase-negative Staphylococcus sp. isolates were excluded. by the total number of isolates. ESBL: extended spectrum beta-lactamases.